Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

NCT00227734 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: capecitabine and oxaliplatin + cetuximab
DRUG: capecitabine and oxaliplatin

Sponsor

Swiss Cancer Institute